6-iodo-4-((3-methoxyphenyl)amino)-8-methylquinoline-3-carboxamide | 807325-83-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 6-iodo-4-((3-methoxyphenyl)amino)-8-methylquinoline-3-carboxamide
• 英文别名: 6-iodo-4-(3-methoxyphenylamino)-8-methylquinoline-3-carboxamide；6-iodo-4-(3-methoxyanilino)-8-methylquinoline-3-carboxamide
• CAS: 807325-83-3
• 化学式: C₁₈H₁₆IN₃O₂
• 分子量: 433.248
• InChiKey: LKRTVQCVFDJPAW-UHFFFAOYSA-N

物化性质

• 沸点：
  575.0±50.0 °C(Predicted)
• 密度：
  1.641±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  24
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  77.2
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  6-iodo-4-((3-methoxyphenyl)amino)-8-methylquinoline-3-carboxamide 在 Oxone 、 tris-(dibenzylideneacetone)dipalladium(0) 、 potassium tert-butylate 、 双(2-二苯基磷苯基)醚 、 sodium hydroxide 作用下， 以 乙醇 、 N,N-二甲基甲酰胺 、 甲苯 为溶剂， 生成 3-({3-氨基甲酰基-4-[(3-甲氧基苯基)氨基]-8-甲基-6-喹啉基}磺酰基)苯甲酸
  参考文献：
  名称：

  Repurposing Human PDE4 Inhibitors for Neglected Tropical Diseases. Evaluation of Analogs of the Human PDE4 Inhibitor GSK-256066 as Inhibitors of PDEB1 ofTrypanosoma brucei

  摘要：

  Cyclic nucleotide phosphodiesterases (PDEs) have been identified as important enzyme targets for drug development in both humans and Trypanosoma brucei, the causative agent of human African trypanosomiasis. With this in mind, we recently reported the profiling of a range of human phosphodiesterase inhibitors, showing that human PDE4 inhibitors tend to display the best potency against the trypanosomal phosphodiesterase TbrPDEB1. Among these was GSK‐256066, a potent inhibitor of human PDE4 and a weak inhibitor of TbrPDEB1. In this report, we describe the results of a structure–activity relationship study of this chemotype, leading to the discovery of analogs with improved potency against TbrPDEB1 and micromolar inhibition of T. brucei cellular growth. We rationalize the potency trends via molecular docking of the new inhibitors into a recently reported apo structure of TbrPDEB1. The studies in this article will inform future efforts in repurposing human PDE inhibitors as antitrypanosomal agents.

  DOI：

  10.1111/cbdd.12443
• 作为产物：
  描述：

  6-碘-8-甲基-4-氧代-1,4-二氢喹啉-3-羧酸乙酯 在 ammonium hydroxide 、 氯化亚砜 、 N,N-二甲基甲酰胺 、 sodium hydroxide 作用下， 以 乙醇 、 水 、 乙腈 为溶剂， 反应 3.0h， 生成 6-iodo-4-((3-methoxyphenyl)amino)-8-methylquinoline-3-carboxamide
  参考文献：
  名称：

  Repurposing Human PDE4 Inhibitors for Neglected Tropical Diseases. Evaluation of Analogs of the Human PDE4 Inhibitor GSK-256066 as Inhibitors of PDEB1 ofTrypanosoma brucei

  摘要：

  Cyclic nucleotide phosphodiesterases (PDEs) have been identified as important enzyme targets for drug development in both humans and Trypanosoma brucei, the causative agent of human African trypanosomiasis. With this in mind, we recently reported the profiling of a range of human phosphodiesterase inhibitors, showing that human PDE4 inhibitors tend to display the best potency against the trypanosomal phosphodiesterase TbrPDEB1. Among these was GSK‐256066, a potent inhibitor of human PDE4 and a weak inhibitor of TbrPDEB1. In this report, we describe the results of a structure–activity relationship study of this chemotype, leading to the discovery of analogs with improved potency against TbrPDEB1 and micromolar inhibition of T. brucei cellular growth. We rationalize the potency trends via molecular docking of the new inhibitors into a recently reported apo structure of TbrPDEB1. The studies in this article will inform future efforts in repurposing human PDE inhibitors as antitrypanosomal agents.

  DOI：

  10.1111/cbdd.12443

文献信息

• BI-FUNCTIONAL QUINOLINE ANALOGS
  申请人：Baker William R.

  公开号：US20110275622A1

  公开（公告）日：2011-11-10

  Provided are compounds of Formula I: wherein X is: R 1 and R 2 together with the phenyl to which they are bound may form a bicyclic, fused heterocyclic ring, and all other variables are as defined herein, as well as their use in treating pulmonary inflammation or bronchoconstriction and compositions comprising and processes for preparing the same.

  提供的是以下化合物的结构式：其中X是：R1和R2，与它们结合的苯基一起可以形成一个螺环的、融合的杂环环，所有其他变量如本文所定义，以及它们在治疗肺部炎症或支气管痉挛中的应用，以及包含它们的组合物和制备这些化合物的方法。
• Bi-functional quinoline analogs
  申请人：Baker William R.

  公开号：US08394829B2

  公开（公告）日：2013-03-12

  Provided are compounds of Formula I: wherein X is: R1 and R2 together with the phenyl to which they are bound may form a bicyclic, fused heterocyclic ring, and all other variables are as defined herein, as well as their use in treating pulmonary inflammation or bronchoconstriction and compositions comprising and processes for preparing the same.

  提供的是I式化合物：其中X为：R1和R2与它们所结合的苯基可能形成一个双环的、融合的杂环环，所有其他变量的定义如本文所述，以及它们在治疗肺部炎症或支气管收缩以及包含它们的组合物和制备这些化合物的过程中的使用。
• BIFUNCTIONAL QUINOLINE DERIVATIVES
  申请人：Gilead Sciences, Inc.

  公开号：EP2569285A1

  公开（公告）日：2013-03-20
• US8394829B2
  申请人：——

  公开号：US8394829B2

  公开（公告）日：2013-03-12
• [EN] BIFUNCTIONAL QUINOLINE DERIVATIVES<br/>[FR] DÉRIVÉS QUINOLINIQUES BIFONCTIONNELS
  申请人：GILEAD SCIENCES INC

  公开号：WO2011143105A1

  公开（公告）日：2011-11-17

  Provided are compounds of Formula (I): Wherein X is:(Formula (II)) or (Formula (III)) R1 and R2 together with the phenyl to which they are bound may form a bicyclic, fused heterocyclic ring, and all other variables are as defined herein, as well as their use in treating pulmonary inflammation or bronchoconstriction and compositions comprising and processes for preparing the same.